Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia.

导出 OA

翻译打印收藏纠错

作者： Dean,Najarian ^[1] ; Ibrahim,Turkoz ^[2] ; R Karl,Knight ^[2] ; Silvana,Galderisi ^[3] ; Hector F,Lamaison ^[4] ; Piotr,Zalitacz ^[5] ; Suresh,Aravind ^[2] ; Ute,Richarz ^[6]

作者单位： Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA. ^[1] Janssen Research & Development, LLC, Titusville, New Jersey, USA. ^[2] University of Campania "Luigi Vanvitelli," Naples, Italy. ^[3] Department of Psychiatry, National University of La Plata (UNLP), Buenos Aires, Argentina. ^[4] Head of Psychiatric Unit, Gorlice Specialist Hospital, Gorlice, Poland. ^[5] Dural Consulting LLC, St Petersburg, Florida, USA (Dr Aravind). ^[6] Janssen Research & Development, Cilag Int., Gubelstrasse, Zug, Switzerland. ^[7]

关键词 Long-term efficacy long-acting injectable open-label extension paliperidone palmitate 6-month schizophrenia

主题词男(雄)性(Male);人类(Humans);成年人(Adult);精神分裂症(Schizophrenia);双盲法(Double-Blind Method)

DOI 10.1093/ijnp/pyad028

PMID 37480362

发布时间 2023-09-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交